Charles Brigden
Chief Executive Officer at Eliptica Ltd.
Profile
Mr. Charles Brigden is Senior Vice President & Head-Business Development at BTG Plc.
He received his MBA from Columbia Business School.
Charles Brigden active positions
| Companies | Position | Start |
|---|---|---|
Eliptica Ltd.
 Eliptica Ltd. Miscellaneous Commercial ServicesCommercial Services Eliptica Ltd. is a British company that specializes in research and experimental development on biotechnology. The private company was founded in 2022 by Markus Ralser, Aleksej Zelezniak, Charles Brigden. Charles Brigden has been the CEO since 2022. | Chief Executive Officer | 2022-03-31 |
Former positions of Charles Brigden
| Companies | Position | End |
|---|---|---|
| BTG | Corporate Officer/Principal | - |
Training of Charles Brigden
| Columbia Business School | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
BTG Ltd.
 BTG Ltd. Pharmaceuticals: MajorHealth Technology BTG Ltd. is a global healthcare company, which focuses on interventional medicine that can help physicians to treat patients through minimally invasive procedures. It operates through the following segments: Product, Licensing, and Other. The firm's products include CroFab, DigiFab, Voraxage. The company was founded on December 12, 1991 and is headquartered in Farnham, the United Kingdom. | Health Technology |
Eliptica Ltd.
Eliptica Ltd. Miscellaneous Commercial ServicesCommercial Services Eliptica Ltd. is a British company that specializes in research and experimental development on biotechnology. The private company was founded in 2022 by Markus Ralser, Aleksej Zelezniak, Charles Brigden. Charles Brigden has been the CEO since 2022. | Commercial Services |
- Stock Market
- Insiders
- Charles Brigden
